 | • レポートコード：GIR-107A14931 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、生物学的製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。生物学的製剤の種類別市場規模（モノクローナル抗体、治療用タンパク質、ワクチン）、用途別市場規模（臨床検査、検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・生物学的製剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aurobindo Pharma Ltd.、Concord Biotech、GlaxoSmithKline Plc.、H. Lundbeck A/S、Novartis Global、Retractable Technologies, Inc.、Smith Medical、AstraZeneca、Pfizer Inc.、Merck and Co. Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、治療用タンパク質、ワクチン ・用途別分析2016年-2026年：臨床検査、検査室、その他 ・生物学的製剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・生物学的製剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・生物学的製剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・生物学的製剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・生物学的製剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Biologic Therapeutic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biologic Therapeutic Drug size is estimated to be USD XX million in 2026 from USD XX million in 2020, with a change XX% between 2020 and 2021. The global Biologic Therapeutic Drug market size is expected to grow at a CAGR of XX% for the next five years.
Market segmentation
Biologic Therapeutic Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Market segment by Application, can be divided into
Clinical Medicine
Laboratory
Others
Market segment by players, this report covers
Aurobindo Pharma Ltd.
Concord Biotech
GlaxoSmithKline Plc.
H. Lundbeck A/S
Novartis Global
Retractable Technologies, Inc.
Smith Medical
AstraZeneca
Pfizer Inc.
Merck and Co. Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biologic Therapeutic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biologic Therapeutic Drug, with revenue, gross margin and global market share of Biologic Therapeutic Drug from 2019 to 2021.
Chapter 3, the Biologic Therapeutic Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Biologic Therapeutic Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Biologic Therapeutic Drug research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Biologic Therapeutic Drug
1.2 Classification of Biologic Therapeutic Drug by Type
1.2.1 Overview: Global Biologic Therapeutic Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biologic Therapeutic Drug Revenue Market Share by Type in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Therapeutic Proteins
1.2.5 Vaccines
1.3 Global Biologic Therapeutic Drug Market by Application
1.3.1 Overview: Global Biologic Therapeutic Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinical Medicine
1.3.3 Laboratory
1.3.4 Others
1.4 Global Biologic Therapeutic Drug Market Size & Forecast
1.5 Global Biologic Therapeutic Drug Market Size and Forecast by Region
1.5.1 Global Biologic Therapeutic Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biologic Therapeutic Drug Market Size by Region, (2016-2021)
1.5.3 North America Biologic Therapeutic Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Biologic Therapeutic Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biologic Therapeutic Drug Market Size and Prospect (2016-2026)
1.5.6 South America Biologic Therapeutic Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biologic Therapeutic Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologic Therapeutic Drug Market Drivers
1.6.2 Biologic Therapeutic Drug Market Restraints
1.6.3 Biologic Therapeutic Drug Trends Analysis
2 Company Profiles
2.1 Aurobindo Pharma Ltd.
2.1.1 Aurobindo Pharma Ltd. Details
2.1.2 Aurobindo Pharma Ltd. Major Business
2.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product and Solutions
2.1.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Aurobindo Pharma Ltd. Recent Developments and Future Plans
2.2 Concord Biotech
2.2.1 Concord Biotech Details
2.2.2 Concord Biotech Major Business
2.2.3 Concord Biotech Biologic Therapeutic Drug Product and Solutions
2.2.4 Concord Biotech Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Concord Biotech Recent Developments and Future Plans
2.3 GlaxoSmithKline Plc.
2.3.1 GlaxoSmithKline Plc. Details
2.3.2 GlaxoSmithKline Plc. Major Business
2.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product and Solutions
2.3.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Plc. Recent Developments and Future Plans
2.4 H. Lundbeck A/S
2.4.1 H. Lundbeck A/S Details
2.4.2 H. Lundbeck A/S Major Business
2.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Product and Solutions
2.4.4 H. Lundbeck A/S Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 H. Lundbeck A/S Recent Developments and Future Plans
2.5 Novartis Global
2.5.1 Novartis Global Details
2.5.2 Novartis Global Major Business
2.5.3 Novartis Global Biologic Therapeutic Drug Product and Solutions
2.5.4 Novartis Global Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis Global Recent Developments and Future Plans
2.6 Retractable Technologies, Inc.
2.6.1 Retractable Technologies, Inc. Details
2.6.2 Retractable Technologies, Inc. Major Business
2.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Product and Solutions
2.6.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Retractable Technologies, Inc. Recent Developments and Future Plans
2.7 Smith Medical
2.7.1 Smith Medical Details
2.7.2 Smith Medical Major Business
2.7.3 Smith Medical Biologic Therapeutic Drug Product and Solutions
2.7.4 Smith Medical Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Smith Medical Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Biologic Therapeutic Drug Product and Solutions
2.8.4 AstraZeneca Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Biologic Therapeutic Drug Product and Solutions
2.9.4 Pfizer Inc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Inc. Recent Developments and Future Plans
2.10 Merck and Co. Inc.
2.10.1 Merck and Co. Inc. Details
2.10.2 Merck and Co. Inc. Major Business
2.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Product and Solutions
2.10.4 Merck and Co. Inc. Biologic Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Merck and Co. Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biologic Therapeutic Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biologic Therapeutic Drug Players Market Share
3.2.2 Top 10 Biologic Therapeutic Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Biologic Therapeutic Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biologic Therapeutic Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Biologic Therapeutic Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biologic Therapeutic Drug Revenue Market Share by Application (2016-2021)
5.2 Biologic Therapeutic Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biologic Therapeutic Drug Revenue by Type (2016-2026)
6.2 North America Biologic Therapeutic Drug Revenue by Application (2016-2026)
6.3 North America Biologic Therapeutic Drug Market Size by Country
6.3.1 North America Biologic Therapeutic Drug Revenue by Country (2016-2026)
6.3.2 United States Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biologic Therapeutic Drug Revenue by Type (2016-2026)
7.2 Europe Biologic Therapeutic Drug Revenue by Application (2016-2026)
7.3 Europe Biologic Therapeutic Drug Market Size by Country
7.3.1 Europe Biologic Therapeutic Drug Revenue by Country (2016-2026)
7.3.2 Germany Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
7.3.3 France Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biologic Therapeutic Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Biologic Therapeutic Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Region
8.3.1 Asia-Pacific Biologic Therapeutic Drug Revenue by Region (2016-2026)
8.3.2 China Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
8.3.5 India Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biologic Therapeutic Drug Revenue by Type (2016-2026)
9.2 South America Biologic Therapeutic Drug Revenue by Application (2016-2026)
9.3 South America Biologic Therapeutic Drug Market Size by Country
9.3.1 South America Biologic Therapeutic Drug Revenue by Country (2016-2026)
9.3.2 Brazil Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biologic Therapeutic Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Biologic Therapeutic Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Country
10.3.1 Middle East & Africa Biologic Therapeutic Drug Revenue by Country (2016-2026)
10.3.2 Turkey Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Biologic Therapeutic Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Biologic Therapeutic Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biologic Therapeutic Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biologic Therapeutic Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biologic Therapeutic Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biologic Therapeutic Drug Revenue Market Share by Region (2021-2026)
Table 6. Aurobindo Pharma Ltd. Corporate Information, Head Office, and Major Competitors
Table 7. Aurobindo Pharma Ltd. Major Business
Table 8. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product and Solutions
Table 9. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Concord Biotech Corporate Information, Head Office, and Major Competitors
Table 11. Concord Biotech Major Business
Table 12. Concord Biotech Biologic Therapeutic Drug Product and Solutions
Table 13. Concord Biotech Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Plc. Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Plc. Major Business
Table 16. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product and Solutions
Table 17. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. H. Lundbeck A/S Corporate Information, Head Office, and Major Competitors
Table 19. H. Lundbeck A/S Major Business
Table 20. H. Lundbeck A/S Biologic Therapeutic Drug Product and Solutions
Table 21. H. Lundbeck A/S Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis Global Corporate Information, Head Office, and Major Competitors
Table 23. Novartis Global Major Business
Table 24. Novartis Global Biologic Therapeutic Drug Product and Solutions
Table 25. Novartis Global Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Retractable Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Retractable Technologies, Inc. Major Business
Table 28. Retractable Technologies, Inc. Biologic Therapeutic Drug Product and Solutions
Table 29. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Smith Medical Corporate Information, Head Office, and Major Competitors
Table 31. Smith Medical Major Business
Table 32. Smith Medical Biologic Therapeutic Drug Product and Solutions
Table 33. Smith Medical Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 35. AstraZeneca Major Business
Table 36. AstraZeneca Biologic Therapeutic Drug Product and Solutions
Table 37. AstraZeneca Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Inc. Major Business
Table 40. Pfizer Inc. Biologic Therapeutic Drug Product and Solutions
Table 41. Pfizer Inc. Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Merck and Co. Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Merck and Co. Inc. Major Business
Table 44. Merck and Co. Inc. Biologic Therapeutic Drug Product and Solutions
Table 45. Merck and Co. Inc. Biologic Therapeutic Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Biologic Therapeutic Drug Revenue (USD Million) by Players (2019-2021)
Table 47. Global Biologic Therapeutic Drug Revenue Share by Players (2019-2021)
Table 48. Breakdown of Biologic Therapeutic Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Biologic Therapeutic Drug Players Head Office, Products and Services Provided
Table 50. Biologic Therapeutic Drug Mergers & Acquisitions in the Past Five Years
Table 51. Biologic Therapeutic Drug New Entrants and Expansion Plans
Table 52. Global Biologic Therapeutic Drug Revenue (USD Million) by Type (2016-2021)
Table 53. Global Biologic Therapeutic Drug Revenue Share by Type (2016-2021)
Table 54. Global Biologic Therapeutic Drug Revenue Forecast by Type (2021-2026)
Table 55. Global Biologic Therapeutic Drug Revenue by Application (2016-2021)
Table 56. Global Biologic Therapeutic Drug Revenue Forecast by Application (2021-2026)
Table 57. North America Biologic Therapeutic Drug Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Biologic Therapeutic Drug Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Biologic Therapeutic Drug Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Biologic Therapeutic Drug Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Biologic Therapeutic Drug Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Biologic Therapeutic Drug Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Biologic Therapeutic Drug Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Biologic Therapeutic Drug Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Biologic Therapeutic Drug Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Biologic Therapeutic Drug Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Biologic Therapeutic Drug Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Biologic Therapeutic Drug Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Biologic Therapeutic Drug Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Biologic Therapeutic Drug Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Biologic Therapeutic Drug Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Biologic Therapeutic Drug Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Biologic Therapeutic Drug Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Biologic Therapeutic Drug Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Biologic Therapeutic Drug Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Biologic Therapeutic Drug Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Biologic Therapeutic Drug Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Biologic Therapeutic Drug Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Biologic Therapeutic Drug Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Biologic Therapeutic Drug Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Biologic Therapeutic Drug Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Biologic Therapeutic Drug Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Biologic Therapeutic Drug Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Biologic Therapeutic Drug Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Biologic Therapeutic Drug Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Biologic Therapeutic Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biologic Therapeutic Drug Picture
Figure 2. Global Biologic Therapeutic Drug Revenue Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Therapeutic Proteins
Figure 5. Vaccines
Figure 6. Biologic Therapeutic Drug Revenue Market Share by Application in 2020
Figure 7. Clinical Medicine Picture
Figure 8. Laboratory Picture
Figure 9. Others Picture
Figure 10. Global Biologic Therapeutic Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Biologic Therapeutic Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Biologic Therapeutic Drug Revenue Market Share by Region (2016-2026)
Figure 13. Global Biologic Therapeutic Drug Revenue Market Share by Region in 2020
Figure 14. North America Biologic Therapeutic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Biologic Therapeutic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Biologic Therapeutic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Biologic Therapeutic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Biologic Therapeutic Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Biologic Therapeutic Drug Market Drivers
Figure 20. Biologic Therapeutic Drug Market Restraints
Figure 21. Biologic Therapeutic Drug Market Trends
Figure 22. Aurobindo Pharma Ltd. Recent Developments and Future Plans
Figure 23. Concord Biotech Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Plc. Recent Developments and Future Plans
Figure 25. H. Lundbeck A/S Recent Developments and Future Plans
Figure 26. Novartis Global Recent Developments and Future Plans
Figure 27. Retractable Technologies, Inc. Recent Developments and Future Plans
Figure 28. Smith Medical Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Pfizer Inc. Recent Developments and Future Plans
Figure 31. Merck and Co. Inc. Recent Developments and Future Plans
Figure 32. Global Biologic Therapeutic Drug Revenue Share by Players in 2020
Figure 33. Biologic Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Biologic Therapeutic Drug Revenue Market Share in 2020
Figure 35. Global Top 10 Players Biologic Therapeutic Drug Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Biologic Therapeutic Drug Revenue Share by Type in 2020
Figure 38. Global Biologic Therapeutic Drug Market Share Forecast by Type (2021-2026)
Figure 39. Global Biologic Therapeutic Drug Revenue Share by Application in 2020
Figure 40. Global Biologic Therapeutic Drug Market Share Forecast by Application (2021-2026)
Figure 41. North America Biologic Therapeutic Drug Sales Market Share by Type (2016-2026)
Figure 42. North America Biologic Therapeutic Drug Sales Market Share by Application (2016-2026)
Figure 43. North America Biologic Therapeutic Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Biologic Therapeutic Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Biologic Therapeutic Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Biologic Therapeutic Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Biologic Therapeutic Drug Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Biologic Therapeutic Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Biologic Therapeutic Drug Revenue Market Share by Region (2016-2026)
Figure 58. China Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Biologic Therapeutic Drug Sales Market Share by Type (2016-2026)
Figure 65. South America Biologic Therapeutic Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Biologic Therapeutic Drug Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Biologic Therapeutic Drug Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Biologic Therapeutic Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Biologic Therapeutic Drug Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Biologic Therapeutic Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の眼科用治療薬市場 2021：企業別、地域別、種類・用途別 The Ophthalmic Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界の治療用BCGワクチン市場 2021：企業別、地域別、種類・用途別 The Therapeutic BCG Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の心血管疾患治療用タンパク質市場 2021：企業別、地域別、種類・用途別 The Therapeutic Proteins for Cardiovascular Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 世界の二重特異性抗体治療市場 2021：企業別、地域別、種類・用途別 The Bispecific Antibody Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の神経生物学的製品市場 2021：企業別、地域別、種類・用途別 The Nerve Biologic Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…